Profound Medical Statistics
Total Valuation
TSX:PRN has a market cap or net worth of CAD 179.12 million. The enterprise value is 137.68 million.
Market Cap | 179.12M |
Enterprise Value | 137.68M |
Important Dates
The last earnings date was Thursday, August 7, 2025.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TSX:PRN has 30.05 million shares outstanding. The number of shares has increased by 18.96% in one year.
Current Share Class | 30.05M |
Shares Outstanding | 30.05M |
Shares Change (YoY) | +18.96% |
Shares Change (QoQ) | +16.57% |
Owned by Insiders (%) | 8.14% |
Owned by Institutions (%) | 51.67% |
Float | 27.61M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 11.09 |
PB Ratio | 3.35 |
P/TBV Ratio | 3.36 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.48 |
EV / Sales | 8.53 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.53, with a Debt / Equity ratio of 0.12.
Current Ratio | 8.53 |
Quick Ratio | 7.00 |
Debt / Equity | 0.12 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -103.78% and return on invested capital (ROIC) is -58.81%.
Return on Equity (ROE) | -103.78% |
Return on Assets (ROA) | -53.06% |
Return on Invested Capital (ROIC) | -58.81% |
Return on Capital Employed (ROCE) | -96.31% |
Revenue Per Employee | 113,719 |
Profits Per Employee | -391,207 |
Employee Count | 142 |
Asset Turnover | 0.24 |
Inventory Turnover | 0.48 |
Taxes
In the past 12 months, TSX:PRN has paid 58,646 in taxes.
Income Tax | 58,646 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.98% in the last 52 weeks. The beta is 0.31, so TSX:PRN's price volatility has been lower than the market average.
Beta (5Y) | 0.31 |
52-Week Price Change | -53.98% |
50-Day Moving Average | 8.08 |
200-Day Moving Average | 8.97 |
Relative Strength Index (RSI) | 19.26 |
Average Volume (20 Days) | 9,511 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:PRN had revenue of CAD 16.15 million and -55.55 million in losses. Loss per share was -2.01.
Revenue | 16.15M |
Gross Profit | 11.19M |
Operating Income | -57.72M |
Pretax Income | -55.49M |
Net Income | -55.55M |
EBITDA | -56.63M |
EBIT | -57.72M |
Loss Per Share | -2.01 |
Balance Sheet
The company has 48.00 million in cash and 6.56 million in debt, giving a net cash position of 41.44 million or 1.38 per share.
Cash & Cash Equivalents | 48.00M |
Total Debt | 6.56M |
Net Cash | 41.44M |
Net Cash Per Share | 1.38 |
Equity (Book Value) | 53.54M |
Book Value Per Share | 1.78 |
Working Capital | 58.76M |
Cash Flow
Operating Cash Flow | -47.19M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 69.29% |
Operating Margin | -357.47% |
Pretax Margin | -343.65% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TSX:PRN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -18.96% |
Shareholder Yield | n/a |
Earnings Yield | -31.01% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on October 16, 2019. It was a reverse split with a ratio of 0.1.
Last Split Date | Oct 16, 2019 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |